BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Valproic acid
,
rs7903146
,
SIRT1
,
Fatty acid metabolic process
,
Diabetes mellitus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
myelodysplastic syndrome
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
MME
MECOM
COL6A3
EIF1AY
IRF1
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
heterocyclic compound binding
organic cyclic compound binding
heterocycle metabolic process
organic cyclic compound metabolic process
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Myelodysplastic syndrome - gene expression profiling of U2AF1 mutant and wildtype CD34+ cells
Pediatric myelodysplastic syndrome gene expression profiles associated with disease subtype
Myelodysplastic syndrome-derived cells treated with the DNA methyl transferase inhibitor decitabine
Myeloid bone marrow cells from ASXL1 mutant mice model
PBMCs of acute myeloid leukemia or myelodysplastic syndrome patients with CPI-613 response
Explore Curated Studies Results
Literature
Most Relevant Literature
Bilateral lung 99mTc-MDP uptake on the bone scintigraphy in the myelodysplastic syndromes (MDS).
Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome].
Application of DNA methyltransferase inhibitors for myelodysplastic syndrome].
Myelodysplastic syndromes: therapy and outlook.
Deregulation of microRNAs in myelodysplastic syndrome.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes
Belinostat in Treating Patients With Myelodysplastic Syndromes
CPX-351 in Higher Risk Myelodysplastic Syndromes
Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients
BMS-986253 in Myelodysplastic Syndromes
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ